Suzhou Wentai Pharmaceutical Technology

Suzhou Wentai Pharmaceutical Technology is a biopharmaceutical company specializing in the development of high-end long-acting injectable formulations, with a core focus on microsphere technology. The company aims to improve existing therapies through its proprietary drug delivery platforms, creating "value-added" medicines (Class 2 new drugs in China) that provide sustained release and improved patient compliance. Its pipeline targets significant therapeutic areas including psychiatry, endocrinology, and oncology. Headquartered in Suzhou Industrial Park, Wentai integrates R&D with pilot-scale and commercial manufacturing capabilities. The firm is backed by prominent venture capital investors and led by experts in pharmaceutical formulation.